Skip to main content
. 2021 Jul 27;12(2):108–115. doi: 10.4103/jmh.jmh_86_21

Table 1.

Changes in each item of Menopause Rating Scale II score over time (n=70)

MRS-II parameters Baseline Week 4 Week 8 Week 12 Percentage difference baseline to 12th week P*
Somatic subscale
 Joint muscular discomfort 2.5 (2.2-2.7) 1.8 (1.6-2.1) 1.3 (1.1-1.5) 0.8 (0.5-1.0) 68.00 <0.001
 Sleep problems 2.7 (2.5-2.9) 2.3 (2.0-2.5) 1.7 (1.5-1.9) 0.8 (0.6-1.0) 70.37 <0.001
 Heart discomfort 2.8 (2.6-3.1) 2.3 (2.0-2.5) 1.6 (1.3-1.8) 0.8 (0.5-1.0) 71.43 <0.001
 Hot flushes 2.8 (2.6-3.0) 2.2 (2.0-2.4) 1.5 (1.3-1.7) 0.7 (0.5-0.9) 75.00 <0.001
Urogenital subscale
 Dryness of vagina 1.9 (1.7-2.1) 1.6 (1.3-1.8) 1.2 (1.0-1.5) 0.8 (0.5-1.0) 57.89 <0.001
 Bladder problems 2.1 (1.9-2.4) 1.8 (1.5-2.0) 1.3 (1.1-1.5) 0.9 (0.6-1.1) 57.14 <0.001
 Sexual problems 1.9 (1.6-2.1) 1.6 (1.4-1.8) 1.2 (1.0-1.4) 0.7 (0.5-0.9) 63.16 <0.001
Psychological subscale
 Physical and mental exhaustion 2.4 (2.2-2.6) 1.9 (1.7-2.1) 1.4 (1.2-1.6) 0.8 (0.6-1.0) 66.67 <0.001
 Anxiety 2.4 (2.1-2.6) 1.9 (1.6-2.1) 1.3 (1.0-1.5) 0.8 (0.6-1.0) 66.67 <0.001
 Irritability 2.6 (2.4-2.9) 1.9 (1.7-2.1) 1.4 (1.2-1.6) 0.9 (0.7-1.1) 65.38 <0.001
 Depressive mood 2.6 (2.4-2.8) 2.1 (1.9-2.3) 1.4 (1.2-1.6) 0.7 (0.5-0.9) 73.08 <0.001

*Comparison between results at baseline and 12 weeks. The data are represented by mean (95% CI). ANOVA was performed. MRS: Menopause Rating Scale, CI: Confidence interval, ANOVA: Analysis of variance